{"id":25559,"date":"2025-02-05T21:32:36","date_gmt":"2025-02-05T13:32:36","guid":{"rendered":"https:\/\/flcube.com\/?p=25559"},"modified":"2025-02-05T21:32:39","modified_gmt":"2025-02-05T13:32:39","slug":"tofflon-to-join-shanghai-biomedical-ma-fund-with-leading-firms","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=25559","title":{"rendered":"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms"},"content":{"rendered":"\n

China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171<\/a>), a total solution service provider for global pharmaceutical companies, plans to jointly establish the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise (Limited Partnership) with Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and MediTrust Health, among others.<\/p>\n\n\n\n

Investment Details<\/strong>
Tofflon will contribute RMB 200 million to the fund, which is expected to have a management scale of RMB 5.01 billion. This strategic move aims to leverage the combined expertise and resources of leading industry players to drive innovation and growth in the biomedical sector.<\/p>\n\n\n\n

Future Outlook<\/strong>
The establishment of the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise marks a significant step in fostering collaboration and investment in the biomedical industry. By pooling resources and expertise, the partnership aims to support the development of innovative therapies and technologies, ultimately contributing to advancements in global healthcare.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171), a total solution service provider…<\/p>\n","protected":false},"author":1,"featured_media":25560,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[20,296,596,196,3558,3557],"class_list":["post-25559","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-finance","tag-junshi-biosciences","tag-meditrust-health","tag-shanghai-pharmaceuticals","tag-she-300171","tag-tofflon-science-and-technology"],"yoast_head":"\nTofflon to Join Shanghai Biomedical M&A Fund with Leading Firms - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171), a total solution service provider for global pharmaceutical companies, plans to jointly establish the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise (Limited Partnership) with Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and MediTrust Health, among others.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=25559\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms\" \/>\n<meta property=\"og:description\" content=\"China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171), a total solution service provider for global pharmaceutical companies, plans to jointly establish the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise (Limited Partnership) with Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and MediTrust Health, among others.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=25559\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T13:32:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T13:32:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/0512-png.avif\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"422\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms\",\"datePublished\":\"2025-02-05T13:32:36+00:00\",\"dateModified\":\"2025-02-05T13:32:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559\"},\"wordCount\":163,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/0512-png.avif\",\"keywords\":[\"Finance\",\"Junshi Biosciences\",\"MediTrust Health\",\"Shanghai Pharmaceuticals\",\"SHE: 300171\",\"Tofflon Science and Technology\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=25559#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=25559\",\"name\":\"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/0512-png.avif\",\"datePublished\":\"2025-02-05T13:32:36+00:00\",\"dateModified\":\"2025-02-05T13:32:39+00:00\",\"description\":\"China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171), a total solution service provider for global pharmaceutical companies, plans to jointly establish the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise (Limited Partnership) with Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and MediTrust Health, among others.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=25559\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/0512-png.avif\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/0512-png.avif\",\"width\":1080,\"height\":422,\"caption\":\"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=25559#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms - Insight, China's Pharmaceutical Industry","description":"China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171), a total solution service provider for global pharmaceutical companies, plans to jointly establish the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise (Limited Partnership) with Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and MediTrust Health, among others.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=25559","og_locale":"en_US","og_type":"article","og_title":"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms","og_description":"China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171), a total solution service provider for global pharmaceutical companies, plans to jointly establish the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise (Limited Partnership) with Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and MediTrust Health, among others.","og_url":"https:\/\/flcube.com\/?p=25559","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-02-05T13:32:36+00:00","article_modified_time":"2025-02-05T13:32:39+00:00","og_image":[{"width":1080,"height":422,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/0512-png.avif","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=25559#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=25559"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms","datePublished":"2025-02-05T13:32:36+00:00","dateModified":"2025-02-05T13:32:39+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=25559"},"wordCount":163,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=25559#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/0512-png.avif","keywords":["Finance","Junshi Biosciences","MediTrust Health","Shanghai Pharmaceuticals","SHE: 300171","Tofflon Science and Technology"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=25559#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=25559","url":"https:\/\/flcube.com\/?p=25559","name":"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=25559#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=25559#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/0512-png.avif","datePublished":"2025-02-05T13:32:36+00:00","dateModified":"2025-02-05T13:32:39+00:00","description":"China-based Tofflon Science and Technology Group Co., Ltd. (SHE: 300171), a total solution service provider for global pharmaceutical companies, plans to jointly establish the Shanghai Biomedical Mergers and Acquisitions Equity Investment Partnership Enterprise (Limited Partnership) with Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and MediTrust Health, among others.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=25559#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=25559"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=25559#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/0512-png.avif","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/0512-png.avif","width":1080,"height":422,"caption":"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=25559#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Tofflon to Join Shanghai Biomedical M&A Fund with Leading Firms"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/0512-png.avif","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/25559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=25559"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/25559\/revisions"}],"predecessor-version":[{"id":25561,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/25559\/revisions\/25561"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/25560"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=25559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=25559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=25559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}